NCT00014183 2019-11-07ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney CancerUniversity of Maryland, BaltimorePhase 2 Completed
NCT00467077 2017-03-17Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerCalifornia Cancer ConsortiumPhase 2 Terminated21 enrolled 8 charts
NCT00012337 2013-06-24ZD 1839 in Treating Patients With Metastatic Kidney CancerNational Cancer Institute (NCI)Phase 2 Completed